The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer
Open accessAbstract
// Mahdieh Jadaliha 1 , Xinying Zong 1 , Pushkar Malakar 2 , Tania Ray 3 , Deepak K. Singh 1 , Susan M. Freier 4 , Tor Jensen 5 , Supriya G. Prasanth 1 , Rotem Karni 2 , Partha S. Ray 6, 7 , Kannanganattu V. Prasanth 1 1 Department of Cell and Developmental Biology, University of Illinois, Urbana, IL, USA 2 Department of Biochemistry and Molecular Biology, The Hebrew University-Hadassah Medical School, Jerusalem, Israel 3 Onconostic Technologies, Champaign, IL, USA 4 Ionis Pharmaceuticals Inc., Carlsbad, CA, USA 5 Interdisciplinary Health Sciences Initiative, University of Illinois, Urbana, IL, USA 6 Department of Surgery, University of Illinois College of Medicine, Champaign, IL, USA 7 Carle Cancer Center, Urbana, IL, USA Correspondence to: Kannanganattu V. Prasanth, email: kumarp@illinois.edu Partha S. Ray, email: psray@illinois.edu Rotem Karni, email: rotemka@ekmd.huji.ac.il Keywords: breast cancer, nuclear speckle, triple negative breast cancer, lncRNA, basal-like breast cancer cells Received: February 05, 2016 Accepted: May 09, 2016 Published: May 26, 2016 ABSTRACT MALAT1 (metastasis associated lung adenocarcinoma transcript1) is a conserved long non-coding RNA, known to regulate gene expression by modulating transcription and post-transcriptional pre-mRNA processing of a large number of genes. MALAT1 expression is deregulated in various tumors, including breast cancer. However, the significance of such abnormal expression is yet to be fully understood. In this study, we demonstrate that regulation of aggressive breast cancer cell traits by MALAT1 is not predicted solely based on an elevated expression level but is context specific. By performing loss- and gain-of-function studies, both under in vitro and in vivo conditions, we demonstrate that MALAT1 facilitates cell proliferation, tumor progression and metastasis of triple-negative breast cancer (TNBC) cells despite having a comparatively lower expression level than ER or HER2-positive breast cancer cells. Furthermore, MALAT1 regulates the expression of several cancer metastasis-related genes, but displays molecular subtype specific correlations with such genes. Assessment of the prognostic significance of MALAT1 in human breast cancer (n=1992) revealed elevated MALAT1 expression was associated with decreased disease-specific survival in ER negative, lymph node negative patients of the HER2 and TNBC molecular subtypes. Multivariable analysis confirmed MALAT1 to have independent prognostic significance in the TNBC lymph node negative patient subset (HR=2.64, 95%CI 1.35- 5.16, p=0.005). We propose that the functional significance of MALAT1 as a metastasis driver and its potential use as a prognostic marker is most promising for those patients diagnosed with ER negative, lymph node negative breast cancer who might otherwise mistakenly be stratified to have low recurrence risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization
Cailleau, R., Olivé, M., & Cruciger, Q. V. J. (1978) · In Vitro · doi:10.1007/bf02616120 · Cited by 679
Rae, J. M., Creighton, C. J., Meck, J. M., Haddad, B. R., & Johnson, M. D. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9392-8 · Cited by 374
Further evidence to support the melanocytic origin of MDA-MB-435
Ellison, G. (2002) · Molecular Pathology · doi:10.1136/mp.55.5.294 · Cited by 164
Xiang, L., Gilkes, D. M., Chaturvedi, P., Luo, W., Hu, H., Takano, N., Liang, H., & Semenza, G. L. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1102-5 · Cited by 114
Cited by
Long noncoding RNA MALAT1 suppresses breast cancer metastasis
Kim, J., Piao, H.-L., Kim, B.-J., Yao, F., Han, Z., Wang, Y., Xiao, Z., Siverly, A. N., Lawhon, S. E., Ton, B. N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0252-3 · Cited by 771
Emerging roles of long non‐coding RNA in cancer
Sanchez Calle, A., Kawamura, Y., Yamamoto, Y., Takeshita, F., & Ochiya, T. (2018) · Cancer Science · doi:10.1111/cas.13642 · Cited by 590
Nuclear Long Noncoding RNAs: Key Regulators of Gene Expression
Sun, Q., Hao, Q., & Prasanth, K. V. (2018) · Trends in Genetics · doi:10.1016/j.tig.2017.11.005 · Cited by 565
Self-citationDiagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer
Goyal, B., Yadav, S. R. M., Awasthee, N., Gupta, S., Kunnumakkara, A. B., & Gupta, S. C. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188502 · Cited by 358
Epidrugs: targeting epigenetic marks in cancer treatment
Miranda Furtado, C. L., Dos Santos Luciano, M. C., Silva Santos, R. D., Furtado, G. P., Moraes, M. O., & Pessoa, C. (2019) · Epigenetics · doi:10.1080/15592294.2019.1640546 · Cited by 345
New Insights into Long Non-Coding RNA MALAT1 in Cancer and Metastasis
Sun, Y., & Ma, L. (2019) · Cancers · doi:10.3390/cancers11020216 · Cited by 282
MALAT1 Long Non-Coding RNA: Functional Implications
Arun, G., Aggarwal, D., & Spector, D. L. (2020) · Non-Coding RNA · doi:10.3390/ncrna6020022 · Cited by 276
MALAT1: a potential biomarker in cancer
Li, Z.-X., Zhu, Q.-N., Zhang, H.-B., Hu, Y., Wang, G., & Zhu, Y.-S. (2018) · Cancer Management and Research · doi:10.2147/cmar.s169406 · Cited by 265
Breast Cancer and the Other Non-Coding RNAs
Dvorská, D., Braný, D., Ňachajová, M., Halašová, E., & Danková, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063280 · Cited by 38
Nuclear speckle proteins form intrinsic and MALAT1-dependent microphases
Shinn, M. K., Tomares, D. T., Liu, V., Pant, A., Qiu, Y., Vitalis, A., Song, Y. J., Ayala, Y., Ruff, K. M., Strout, G. W., et al. (2026) · Cell · doi:10.1016/j.cell.2025.11.026 · Cited by 38
Self-citationIsmail, N. H., Mussa, A., Al-Khreisat, M. J., Mohamed Yusoff, S., Husin, A., Al-Jamal, H. A. N., Johan, M. F., & Islam, M. A. (2023) · Non-Coding RNA · doi:10.3390/ncrna9060068 · Cited by 29
Metadata
- Authors
- Jadaliha, M., Zong, X., Malakar, P., Ray, T., Singh, D. K., Freier, S. M., Jensen, T., Prasanth, S. G., Karni, R., Ray, P. S., & Prasanth, K. V.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-05-26
- Volume
- 7
- Issue
- 26
- Pages
- 40418-40436
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2404824878
- Cited by
- 162
- References
- 6
- FWCI
- 9.95
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.